Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders.

Blood - 24 Dec 2009

Ye Zhaohui, Zhan Huichun, Mali Prashant, Dowey Sarah, Williams Donna M, Jang Yoon-Young, Dang Chi V, Spivak Jerry L, Moliterno Alison R, Cheng Linzhao

Abstract excerpt

Human induced pluripotent stem (iPS) cells derived from somatic cells hold promise to develop novel patient-specific cell therapies and research models for inherited and acquired diseases. We and others previously reprogrammed human adherent cells, such as postnatal fibroblasts to iPS cells, which resemble adherent embryonic stem cells. Here we report derivation of iPS cells from postnatal human blood cells and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, CD34
Share to Bone Marrow Cells

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Erythropoiesis

Share to Fetal Blood

Share to Hematopoiesis

Share to Janus Kinase 2

Share to Leukocyte Common Antigens

Share to Myeloproliferative Disorders

Source

Open in PubMed Open full text

Identifiers

PMID: 19797525
DOI: 10.1182/blood-2009-04-217406
PMCID: PMC2798863

Genes

JAK2

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders.PMID 19797525Read ↗

Modeling blood diseases with human induced pluripotent stem cellsSemantic proximity Read ↗

Generation of induced pluripotent stem cells from peripheral blood CD34 + hematopoietic progenitors of a 31 year old healthy womanSemantic proximity Read ↗

Blood Derived Induced Pluripotent Stem Cells (iPSCs): Benefits, Challenges and the Road AheadSemantic proximity Read ↗

Toward clinical therapies using hematopoietic cells derived from human pluripotent stem cellsSemantic proximity Read ↗

Modeling primitive and definitive erythropoiesis with induced pluripotent stem cellsSemantic proximity Read ↗

Induced Pluripotent Stem Cells as a Tool for Modeling Hematologic Disorders and as a Potential Source for Cell-Based TherapiesSemantic proximity Read ↗

Induced pluripotent stem cells as a tool for gaining new insights into Fanconi anemia.Semantic proximity Read ↗

Recent Updates on Induced Pluripotent Stem Cells in Hematological DisordersSemantic proximity Read ↗

Human induced pluripotent stem cell line banking for the production of rare blood type erythrocytesSemantic proximity Read ↗

A molecular roadmap of definitive erythropoiesis from human induced pluripotent stem cells.Semantic proximity Read ↗

Hematopoietic defects and iPSC disease modeling: lessons learned.Semantic proximity Read ↗

Generation of Induced Pluripotent Stem Cells from Amniotic Fluid Cells of a Fetus with Hb Bart's Disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.